Impiricus’ Post
More Relevant Posts
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> FDA advisors back Lilly’s Alzheimer’s drug, setting stage for approval after delay >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #pharmaceutical #healthcare #pharma
To view or add a comment, sign in
-
Thoughts on this? >> FDA advisors back Lilly’s Alzheimer’s drug, setting stage for approval after delay >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #healthcare #pharma #pharmaceutical
FDA advisors back Lilly’s Alzheimer’s drug, setting stage for approval after delay
https://endpts.com
To view or add a comment, sign in
-
The 340B Drug Pricing Program’s rapid growth has created a complex web of financial and legislative challenges for pharma companies. Ricky Yuen and Nick Porter check in on how pharma and states are responding to the program as it changes. https://bit.ly/3KG2LmT #healthcare #pharma #drugpricing
To view or add a comment, sign in
-
Recruiter by Profession, Gamer by Choice | Data Driven with a Human Touch | Scaling the Platform, Product & Technology Teams @ ZS!
The 340B Drug Pricing Program’s rapid growth has created a complex web of financial and legislative challenges for pharma companies. Ricky Yuen and Nicholas Porter check in on how pharma and states are responding to the program as it changes. #healthcare #pharma #drugpricing
Exploring the evolution of 340B contract pharmacy policies
To view or add a comment, sign in
-
Specialized in Global Leadership and C-Level Hiring | Passionate about Executive Hiring | Industry Mapping | Recruitment Analysis | Strategic Hiring | Market Intelligence | Diversity Hiring | Project Management
The 340B Drug Pricing Program’s rapid growth has created a complex web of financial and legislative challenges for pharma companies. Ricky Yuen and Nicholas Porter check in on how pharma and states are responding to the program as it changes. #healthcare #pharma #drugpricing
Exploring the evolution of 340B contract pharmacy policies
To view or add a comment, sign in
-
Searching for brave minds to help us reimagine healthcare || Human Resource Specialist - Talent Acquisition | Advanced Data Science Lead at ZS | Ex-Goldman Sachs
The 340B Drug Pricing Program’s rapid growth has created a complex web of financial and legislative challenges for pharma companies. Ricky Yuen and Nicholas Porter check in on how pharma and states are responding to the program as it changes. #healthcare #pharma #drugpricing
Exploring the evolution of 340B contract pharmacy policies
To view or add a comment, sign in
-
Thoughts on this? >> Faron details clinical plans for MDS drug; Cara to seek 'strategic' options >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #productmarketing #pharmaceutical #pharma #biotech
Faron details clinical plans for MDS drug; Cara to seek 'strategic' options
https://endpts.com
To view or add a comment, sign in
-
Pharma companies use integrated claims, lab, and market access data to prepare for a successful launch. In this Q&A, three clinical experts explain why: https://ow.ly/9QGR30sA06P. #Pharma #ClaimsData #LabData #MarketAccess
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Faron details clinical plans for MDS drug; Cara to seek 'strategic' options >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #biotech #pharma #productmarketing
Faron details clinical plans for MDS drug; Cara to seek 'strategic' options
https://endpts.com
To view or add a comment, sign in
-
Thoughts on this? >> FDA publishes long-awaited guidance on clinical trial diversity >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #productmarketing #healthcare
FDA publishes long-awaited guidance on clinical trial diversity
https://endpts.com
To view or add a comment, sign in
3,016 followers
Listen to the full conversation at https://impiricus.com/resources/